IPR2015-01514 (Amgen Inc.) (U.S. Patent No. 8,916,157)
- Petitioner: Amgen Inc.
- Patent: U.S. Patent No. 8,916,157
- Patent Title: Formulation of human antibodies for treating TNF-α associated disorders
- Patent Owner: AbbVie Biotechnology Ltd.
IPR2015-01517 (Amgen Inc.) (U.S. Patent No. 8,916,158)
- Petitioner: Amgen Inc.
- Patent: U.S. Patent No. 8,916,158
- Patent Title: Formulation of human antibodies for treating TNF-α associated disorders
- Patent Owner: AbbVie Biotechnology Ltd.